Cost-Effectiveness Analysis of Cefoperazone Sodium/Sulbactam Sodium vs. Levofloxacin in the Treatment of Community Acquired Pneumonia
- VernacularTitle:2种用药方案治疗社区获得性肺炎的成本-效果分析
- Author:
Yue ZHANG
- Publication Type:Journal Article
- Keywords:
Community acquired pneumonia;
Cefoperazone sodium/sulbactam sodium;
Levofloxacin;
Cost-effectiveness analysis
- From:
China Pharmacy
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05) and the cost-effectiveness ratios were 1 898.85 and 1 599.81,respectively.CONCLUSION:Levoflocaxin is superior to cefoperazone sodium/sulbactam sodium for community acquired pneumonia.
